DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,002,505 | -29.8% | 290,960 | +0.5% | 0.02% | -25.0% |
| Q2 2023 | $8,545,506 | +21.8% | 289,580 | -4.9% | 0.02% | +17.6% |
| Q1 2023 | $7,018,675 | -16.4% | 304,630 | +0.9% | 0.02% | -22.7% |
| Q4 2022 | $8,395,005 | -11.0% | 301,870 | -1.8% | 0.02% | -15.4% |
| Q3 2022 | $9,436,000 | +1.8% | 307,460 | -2.4% | 0.03% | +8.3% |
| Q2 2022 | $9,267,000 | -8.5% | 314,890 | 0.0% | 0.02% | +4.3% |
| Q1 2022 | $10,130,000 | -26.5% | 314,890 | +1.9% | 0.02% | -17.9% |
| Q4 2021 | $13,783,000 | -19.3% | 309,040 | -8.8% | 0.03% | -24.3% |
| Q3 2021 | $17,089,000 | -36.9% | 338,730 | -1.9% | 0.04% | -35.1% |
| Q2 2021 | $27,085,000 | +29.3% | 345,300 | -5.9% | 0.06% | +23.9% |
| Q1 2021 | $20,947,000 | -32.5% | 366,840 | -1.0% | 0.05% | -27.0% |
| Q4 2020 | $31,027,000 | +118.1% | 370,430 | -6.7% | 0.06% | +96.9% |
| Q3 2020 | $14,228,000 | +40.8% | 397,110 | -5.0% | 0.03% | +33.3% |
| Q2 2020 | $10,105,000 | +36.0% | 417,910 | -1.5% | 0.02% | +9.1% |
| Q1 2020 | $7,429,000 | -1.2% | 424,270 | -1.7% | 0.02% | +22.2% |
| Q4 2019 | $7,521,000 | +13.4% | 431,740 | -0.3% | 0.02% | +5.9% |
| Q3 2019 | $6,631,000 | -27.6% | 432,840 | -1.8% | 0.02% | -45.2% |
| Q2 2019 | $9,155,000 | -10.5% | 440,980 | +0.2% | 0.03% | -18.4% |
| Q1 2019 | $10,224,000 | +12.3% | 440,310 | -0.0% | 0.04% | 0.0% |
| Q4 2018 | $9,101,000 | -14.7% | 440,520 | -10.2% | 0.04% | 0.0% |
| Q3 2018 | $10,666,000 | +40.5% | 490,610 | -1.5% | 0.04% | +192.3% |
| Q2 2018 | $7,593,000 | -25.8% | 497,930 | -4.2% | 0.01% | -27.8% |
| Q1 2018 | $10,234,000 | +20.7% | 519,770 | -4.1% | 0.02% | +20.0% |
| Q4 2017 | $8,478,000 | – | 542,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
| ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
| Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
| Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
| Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
| Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
| Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
| Artal Group S.A. | 802,899 | $16,564 | 0.71% |